- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2011
- Public Summary Document (PSD) November 2011 PBAC Meeting - PDF
Everolimus – November 2011
Everolimus, tablets, 5 mg and 10 mg, Afinitor® - November 2011
Last updated
2 March 2012
